Fonar Corp (FONR)
16.20
-0.61
(-3.63%)
USD |
NASDAQ |
Apr 22, 16:00
16.17
-0.03
(-0.19%)
After-Hours: 20:00
Fonar Revenue (TTM): 102.42M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 102.42M |
| September 30, 2023 | 101.29M |
| June 30, 2023 | 98.65M |
| March 31, 2023 | 97.68M |
| December 31, 2022 | 96.83M |
| September 30, 2022 | 97.05M |
| June 30, 2022 | 97.59M |
| March 31, 2022 | 97.48M |
| December 31, 2021 | 95.99M |
| September 30, 2021 | 92.68M |
| June 30, 2021 | 89.93M |
| March 31, 2021 | 86.04M |
| December 31, 2020 | 84.64M |
| September 30, 2020 | 84.92M |
| June 30, 2020 | 85.69M |
| March 31, 2020 | 87.37M |
| December 31, 2019 | 88.46M |
| September 30, 2019 | 88.23M |
| June 30, 2019 | 87.19M |
| March 31, 2019 | 85.74M |
| December 31, 2018 | 83.94M |
| September 30, 2018 | 82.89M |
| June 30, 2018 | 81.52M |
| March 31, 2018 | 81.37M |
| December 31, 2017 | 80.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 78.64M |
| June 30, 2017 | 78.04M |
| March 31, 2017 | 75.91M |
| December 31, 2016 | 74.53M |
| September 30, 2016 | 74.49M |
| June 30, 2016 | 73.37M |
| March 31, 2016 | 71.48M |
| December 31, 2015 | 69.95M |
| September 30, 2015 | 68.68M |
| June 30, 2015 | 69.05M |
| March 31, 2015 | 69.20M |
| December 31, 2014 | 69.14M |
| September 30, 2014 | 69.66M |
| June 30, 2014 | 68.50M |
| March 31, 2014 | 69.86M |
| December 31, 2013 | 64.46M |
| September 30, 2013 | 56.46M |
| June 30, 2013 | 49.14M |
| March 31, 2013 | 41.76M |
| December 31, 2012 | 39.63M |
| September 30, 2012 | 39.35M |
| June 30, 2012 | 39.44M |
| March 31, 2012 | 36.23M |
| December 31, 2011 | 35.37M |
| September 30, 2011 | 34.06M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
84.64M
Minimum
Dec 2020
102.42M
Maximum
Dec 2023
92.64M
Average
92.68M
Median
Sep 2021
Revenue (TTM) Benchmarks
| XWELL Inc | 30.11M |
| ProPhase Labs Inc | 44.38M |
| Applied DNA Sciences Inc | 8.996M |
| Veracyte Inc | 361.05M |
| OncoCyte Corp | 1.503M |